Sponsor

Baskent University

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Baskent University appears in 26 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials26
Recruiting shown3
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

26 shown
Periodization-Based Strength Exercise Training in İndividuals With Type 2 DiabetesNCT07659925 · lead sponsor · 2026-05-01
RECRUITING
The Türkiye Heart Failure RegistryNCT06707220 · lead sponsor · 2025-01-08
RECRUITING
The Effect of Digital Technology-Supported Education on Patients Undergoing Breast Reconstruction After Mastectomy: A Randomized Controlled StudyNCT06166953 · lead sponsor · 2024-09-27
RECRUITING
Upper Extremity Skills, Trunk Control, and Body Awareness in Parkinson's DiseaseNCT07639463 · lead sponsor · 2026-06-15
ACTIVE_NOT_RECRUITING
Comparison of Frailty, Physical Fitness Parameters, and Irisin Levels Between Patients With Multiple Sclerosis and Healthy VolunteersNCT07521982 · lead sponsor · 2026-04-01
NOT_YET_RECRUITING
Tidal Model-Based ACT for DepressionNCT07442253 · lead sponsor · 2026-02-26
NOT_YET_RECRUITING
Effects of Qigong Therapy in MS PatientsNCT07473180 · lead sponsor · 2025-12-01
ACTIVE_NOT_RECRUITING
The Effect of Complex Decongestıve Therapy on Oxıdatıve Stress and AntıoxıdantsNCT06572098 · lead sponsor · 2024-04-03
ENROLLING_BY_INVITATION
Balance and Gait in Diabetic NeuropathyNCT05127538 · lead sponsor · 2021-12-10
COMPLETED
Usage Of Artificial Intelligence-Integrated Usg In Application of Pectoral Block In MastectomiesNCT06480045 · lead sponsor · 2021-11-05
COMPLETED
Postoperative Morbidity / Mortality Rates of Patients With Pulmonary HypertensionNCT05565911 · lead sponsor · 2021-10-01
UNKNOWN
Detection of Visual-Auditory Reaction Rates in Individuals With Type 2 DiabetesNCT05725889 · lead sponsor · 2021-07-15
COMPLETED
The Effect of Diabetes Mellitus in Colonoscopy Under SedoanalgesiaNCT04477694 · lead sponsor · 2020-12-27
UNKNOWN
Two Different Dietary Approaches in Body CompositionNCT06139562 · lead sponsor · 2019-09-27
COMPLETED
The Relationship Between Body Mass Index and PeriodontitisNCT04743336 · lead sponsor · 2019-01-01
COMPLETED
Levels of High-Sensitivity C-Reactive Protein in Heart Transplant PatientsNCT03671408 · lead sponsor · 2016-04-20
COMPLETED
New-onset Diabetes and Left Ventricular Hypertrophy in Renal TransplantationNCT01976689 · lead sponsor · 2012-03-01
COMPLETED
Hyperglycemia in a Coronary Intensive Care UnitNCT00984737 · lead sponsor · 2007-05-01
COMPLETED
Effects of Rosiglitazone on Plasma BNP Levels and Left Ventricular DysfunctionNCT00300911 · lead sponsor · 2005-12-01
COMPLETED
Clinical Factors Associated Floppy IrisNCT00472888 · lead sponsor · 2005-11-01
COMPLETED
Effects of Rosiglitazone on Bone in Postmenopausal Diabetic WomenNCT00440375 · lead sponsor · 2005-06-01
COMPLETED
Losartan Therapy in Pulmonary HypertensionNCT00519870 · lead sponsor · 2005-01-01
COMPLETED
Ambulatory Blood Pressure Reduction After Rosiglitazone Treatment In Normotensive Type 2 Diabetic PatientsNCT00290394 · lead sponsor · 2004-03-01
COMPLETED
Effects of Achieving Very Low LDL-Cholesterol After Treatment With Statins on Steroidogenesis and CognitionNCT00522158 · lead sponsor
COMPLETED
Effects of Rosiglitazone on Serum Ghrelin and Peptide YY LevelsNCT00522470 · lead sponsor
COMPLETED
Dietary Antioxidants and Thiol Disulfide Homeostasis in T2DMNCT05688631 · collaborator · 2021-01-03
COMPLETED

Drugs studied in this sponsor's trials

5 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Baskent University as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
rosiglitazone2
atorvastatin1
insulin, regular, human1
losartan1
simvastatin1

Sponsor roles

lead sponsor25
collaborator1
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.